Literature DB >> 2935077

Comparison of the in vitro activities of teicoplanin and vancomycin against Clostridium difficile and their interactions with cholestyramine.

A Pantosti, I Luzzi, R Cardines, P Gianfrilli.   

Abstract

The in vitro activity of teicoplanin was compared with that of vancomycin against fecal isolates of Clostridium difficile. All strains were susceptible to both antibiotics, but teicoplanin was fourfold more active than vancomycin. Cholestyramine was found to bind teicoplanin almost completely, reducing its activity to nondetectable levels.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2935077      PMCID： PMC180345          DOI： 10.1128/AAC.28.6.847

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Anion-exchange resins in pseudomembranous colitis.

Authors:  R H George; D J Youngs; E M Johnson; D W Burdon
Journal:  Lancet       Date:  1978-09-16       Impact factor: 79.321

2.  In vitro activity of teicoplanin and vancomycin against anaerobes.

Authors:  Y Glupczynski; M Labbe; F Crokaert; E Yourassowsky
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

3.  Oral vancomycin for antibiotic-associated pseudomembranous colitis.

Authors:  F Tedesco; R Markham; M Gurwith; D Christie; J G Bartlett
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

4.  Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. II. Extraction and chemical characterization.

Authors:  M R Bardone; M Paternoster; C Coronelli
Journal:  J Antibiot (Tokyo)       Date:  1978-03       Impact factor: 2.649

5.  Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci.

Authors:  C U Tuazon; H Miller
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

6.  Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins.

Authors:  N S Taylor; J G Bartlett
Journal:  J Infect Dis       Date:  1980-01       Impact factor: 5.226

7.  In vitro activity of teichomycin and vancomycin alone and in combination with rifampin.

Authors:  P E Varaldo; E Debbia; G C Schito
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

8.  Analysis of the in vitro interaction between vancomycin and cholestyramine.

Authors:  C Y King; S L Barriere
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

9.  Treatment of Clostridium difficile colitis and diarrhea with vancomycin.

Authors:  J Silva; D H Batts; R Fekety; J F Plouffe; G D Rifkin; I Baird
Journal:  Am J Med       Date:  1981-11       Impact factor: 4.965
  9 in total
  7 in total

Review 1.  From stool transplants to next-generation microbiota therapeutics.

Authors:  Elaine O Petrof; Alexander Khoruts
Journal:  Gastroenterology       Date:  2014-01-08       Impact factor: 22.682

2.  Oral teicoplanin versus oral vancomycin for the treatment of severe Clostridium difficile infection: a prospective observational study.

Authors:  Natasa Popovic; Milos Korac; Zorica Nesic; Branko Milosevic; Aleksandar Urosevic; Djordje Jevtovic; Nikola Mitrovic; Aleksandar Markovic; Jelena Jordovic; Natasa Katanic; Aleksandra Barac; Ivana Milosevic
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-03       Impact factor: 3.267

Review 3.  Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  D M Campoli-Richards; R N Brogden; D Faulds
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 4.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

5.  Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.

Authors:  F de Lalla; R Nicolin; E Rinaldi; P Scarpellini; R Rigoli; V Manfrin; A Tramarin
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

6.  Treatment of Clostridium difficile-associated disease with teicoplanin.

Authors:  F de Lalla; G Privitera; E Rinaldi; G Ortisi; D Santoro; G Rizzardini
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

Review 7.  A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection.

Authors:  Csaba Fehér; Alex Soriano; Josep Mensa
Journal:  Infect Dis Ther       Date:  2016-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.